|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
11/8/16 Biolase, Inc. 10-Q 9/30/16 69:7.6M ActiveDisclosure/FA
10/6/16 Biolase, Inc. 8-K:3,5 9/30/16 1:13K Donnelley Fi… Express/FA
10/5/16 Feinberg Larry N 4 10% Owner² 3:27K Biolase, Inc. Broadridge Fin’l So… Inc
Oracle Associates LLC
Oracle Partners LP
10/4/16 Jack W. Schuler Living Trust 4 10% Owner² 1:9K Biolase, Inc. Sidley Austin LLP/FA
Schuler Jack W
10/4/16 Flynn Harold C Jr. 4 Dir.,Off.² 1:8K Biolase, Inc. DONNELLEY FIN… File16/FA
10/4/16 Clark Paul N 4 Director² 1:8K Biolase, Inc. DONNELLEY FIN… File16/FA
10/4/16 Lord Jonathan T MD 4 Director² 1:6K Biolase, Inc. DONNELLEY FIN… File16/FA
9/7/16 Biolase, Inc. DEF 14A 9/30/16 1:837K Donnelley … Solutions/FA
____________ | ¹ | Filing/Form Types: -K | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-Q | Quarterly Report — Form 10-Q. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|